| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
5 companies
Casdin Partners Master Fund, L.P. is a Director, 10% Owner at LAB with holdings across 5 companies. Recent SEC Form 4 filings include 10 buys and 2 sells.
Estimated insider holdings value: $233.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2022 | MXCT Maxcyte, Inc. | 10% Owner | Sell | 735,786 | $6.15 | $4,525,083.90 | -6.9% | -26.5% | -57.0% | |
| Jul 1, 2022 | MXCT Maxcyte, Inc. | 10% Owner | Sell | 3,235,548 | $4.30 | $13,912,856.40 | -23.2% | +34.5% | -1.7% | |
| Aug 3, 2021 | TNYA Tenaya Therapeutics, Inc. | 10% Owner | Buy | 850,000 | $15.00 | $12,750,000.00 | +35.8% | +36.8% | -72.3% | |
| Jul 30, 2021 | MXCT Maxcyte, Inc. | 10% Owner | Buy | 1,800,000 | $13.00 | $23,400,000.00 | +14.8% | -36.4% | -67.9% | |
| Jul 26, 2021 | ABSI Absci Corp | Director | Buy | 1,562,500 | $16.00 | $25,000,000.00 | +30.1% | -49.7% | -86.4% | |
| Nov 24, 2020 | BLFS Biolife Solutions Inc | 10% Owner | Buy | 1,600,000 | $22.50 | $36,000,000.00 | +27.4% | - | - | |
| Jul 2, 2020 | BLFS Biolife Solutions Inc | 10% Owner | Buy | 990,583 | $14.50 | $14,363,453.50 | +9.5% | - | - | |
| May 22, 2020 | BLFS Biolife Solutions Inc | 10% Owner | Buy | 476,191 | $10.50 | $5,000,005.50 | +10.9% | - | - | |
| May 14, 2020 | BLFS Biolife Solutions Inc | 10% Owner | Buy | 1,904,762 | $10.50 | $20,000,001.00 | +77.2% | - | - | |
| Nov 20, 2019 | BLFS Biolife Solutions Inc | 10% Owner | Buy | 40,000 | $15.41 | $616,536.00 | +0.8% | - | - |